Product Code: MZO
FDA class 2
Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus
Unknown
The Hepatitis C Virus (HCV) Enzyme Linked Immunosorbent Assay is an in vitro diagnostic test used to detect antibodies against HCV in patient serum or plasma, supporting the diagnosis of hepatitis C infection. HCV testing is critical for both clinical diagnosis and blood donor screening. Classified as FDA Class 2, it requires 510(k) premarket clearance. This device is reviewed by the Microbiology panel.
510(k)s
1
FEI Numbers
24
Registration Numbers
24
Unique Applicants
1
Years Active
—
Basic Information
- Product Code
- MZO
- Device Class
- FDA class 2
- Medical Specialty
- Unknown
- Review Panel
- MI
- Submission Type
- 1
Device Characteristics
✗
GMP Exempt
✗
Implant
✗
Life Sustain/Support
✗
Third Party
—
Summary Malfunction Reporting
510(k) Clearance History
Loading...
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K221693 | Elecsys Anti-HCV II (08837031190) | Jan 04, 2023 | Substantially Equivalent | Roche Diagnostics |
FEI Numbers
This FDA classification entry is associated with 24 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 24 registration numbers. Click on an entry to view related FDA registrations.